Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis.
Transglutaminase (EC 2.3.2.13) activity in chemically induced rat hepatocellular carcinomas was reduced by some 65% when compared to normal rat livers. The majority of the remaining activity (approx. 85%) was found in the particulate fraction. The use of non-ionic detergent to extract the transglutaminase activity present in both normal and tumour tissue followed by its separation on a Mono-Q column revealed two distinct peaks of activity. These peaks of activity were equivalent to those previously identified as a membrane-bound transglutaminase and the more characteristic cytosolic or tissue transglutaminase. The ratio of the activity of the cytosolic enzyme to that of the membrane-bound enzyme in normal liver was calculated as 5:1. In hepatocellular carcinomas, this ratio was reduced to 0.4:1. No significant change in the activity of the membrane-bound enzyme was detectable in tumour tissue. Comparison of the cytosolic enzyme found in hepatocellular carcinomas with that found in normal liver indicated no change in its molecular weight, Km,app for putrescine incorporation into N,N'-dimethylcasein and sensitivity to activation by Ca2+. These observations suggest that the reduction in transglutaminase activity observed in the hepatocellular carcinoma is due to a selective reduction in the expression of the cytosolic transglutaminase.
D000818:Animals; D002277:Carcinoma / Q000139:chemically induced / Q000201:enzymology*; D002471:Cell Transformation, Neoplastic / Q000201:enzymology*; D002474:Cell-Free System; D003600:Cytosol / Q000201:enzymology*; D004052:Diethylnitrosamine; D008099:Liver / Q000201:enzymology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000201:enzymology*; D008297:Male; D051381:Rats; D011503:Transglutaminases / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000201:enzymology
D004052:Diethylnitrosamine; D011503:Transglutaminases